Boston Scientific Launches Top-selling Stent In Japan
This article was originally published in PharmAsia News
Boston Scientific Corp launched Promus Element drug eluting stent in Japan March 1.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.